accessnewage.com
Feature

NAD+ Nasal Spray: What the Evidence Supports

By Editorial Team · Published 12 October 2026

NAD+ nasal sprays are marketed as a way to raise levels of a coenzyme involved in cellular energy metabolism without the inconvenience of an intravenous drip. The evidence for them is thin. There is no published body of clinical research demonstrating that a spray delivers meaningful quantities of NAD+ into the bloodstream or the brain, and the molecule itself is large and poorly suited to crossing mucosal membranes intact. What exists is a plausible-sounding mechanism, a growing consumer market, and a great deal of extrapolation from research done by other routes of administration.

That gap between mechanism and evidence matters in a wellness sector where the language of longevity has become a selling point. Readers who follow biohacking, supplement trends or longevity clinics will have encountered NAD+ in several forms: infusions, capsules, sublingual tablets and now sprays. The question worth asking is not whether NAD+ matters - it clearly does, as a cofactor in reactions that cells depend on - but whether this particular delivery method does anything useful, and how a sensible person would evaluate the claim.

What is NAD+ and why does it attract attention?

Nicotinamide adenine dinucleotide is a coenzyme present in every living cell. It participates in redox reactions, meaning it shuttles electrons in the processes that convert nutrients into usable energy. It is also a substrate for enzymes involved in DNA repair and in the regulation of gene expression. Without it, cells cannot function.

Levels of NAD+ tend to decline with age, and this decline has been observed across species and tissue types. That observation is the seed from which an entire industry has grown. If NAD+ falls as we age, the reasoning goes, then restoring it might influence the ageing process itself. That is a hypothesis, not a finding. Researchers continue to debate how much of the age-related decline is a cause of dysfunction rather than a consequence of it, and whether raising levels in humans produces meaningful changes in health outcomes.

What is well established is that the body tightly regulates NAD+ through a recycling pathway and through synthesis from precursors such as nicotinamide riboside and nicotinamide mononucleotide. Oral supplements of those precursors are the most studied consumer-facing route. Intravenous NAD+ is offered in clinical settings. Nasal delivery is a newer and much less examined option.

How would a nasal spray even work?

The theory behind nasal administration rests on the anatomy of the nasal cavity. The olfactory region sits close to the brain, and there is a long-standing research interest in whether substances applied there can bypass the blood-brain barrier via olfactory or trigeminal nerve pathways. This is a real area of inquiry, studied in the context of certain neurological drugs.

Whether the same logic applies to NAD+ is a separate question. NAD+ is a relatively large, charged molecule. Absorption across nasal epithelium is limited by size, charge and the presence of enzymes that break it down. A spray also has practical constraints: the volume that can be delivered is small, much of it ends up swallowed rather than absorbed, and formulation quality varies enormously between products.

Delivery is the weak link

Even if a product genuinely contains NAD+, the amount that reaches circulation after nasal administration is the variable that determines whether anything happens at all. Most consumer products do not publish pharmacokinetic data. Without that data, claims about raising systemic NAD+ levels are assumptions rather than measurements.

Is there any research on NAD+ nasal spray specifically?

Not in any substantial form. Searching the published literature for nasal NAD+ administration in humans returns very little. The evidence base for NAD+ and its precursors comes overwhelmingly from oral and intravenous routes, from animal models, and from laboratory work on cell cultures. None of that can be straightforwardly transferred to a spray.

This is a familiar pattern in the supplement world. A mechanism is established in one context, a delivery method is invented for commercial reasons, and the two are presented as if they were connected by evidence. They are not. The honest position is that nasal NAD+ is an untested delivery route with a plausible-sounding rationale and no clinical confirmation.

That does not make it dangerous by default. It does mean that anyone considering it should understand they are participating in an experiment rather than following a recommendation grounded in data.

What should you check before buying one?

If you decide to explore this category, the practical questions are about sourcing and transparency rather than marketing language.

It is also worth reading around the wider category before committing. Services that dispense compounded preparations, including a NAD+ nasal spray, typically publish information about their sourcing, their pharmacy partners and the limits of what they claim. Comparing that information across suppliers is more informative than comparing prices alone.

Are there risks or side effects to consider?

Reported reactions to nasal products in general include irritation, dryness, sneezing and occasional nosebleeds. These are local effects and usually resolve. Because formal safety data for nasal NAD+ in humans is scarce, any systemic effects are simply not well characterised.

More significant is the risk of substituting a spray for something with a real evidence base. If someone is managing a diagnosed condition, or taking prescription medication, adding an unregulated product to the mix introduces the possibility of interactions that nobody has studied. That is a conversation to have with a qualified clinician who knows your history, not with a retailer.

There is also a quality risk. Products sold without proper testing can contain contaminants, or contain nothing at all. The absence of a regulatory framework for consumer nasal sprays means the burden of due diligence falls on the buyer.

How does this fit into a broader wellness routine?

NAD+ sits within a cluster of interventions aimed at cellular health: sleep optimisation, exercise, dietary patterns, and various supplements. Of these, the fundamentals have by far the strongest supporting evidence. Sleep, movement and nutrition influence NAD+ metabolism indirectly and are not dependent on any product being absorbed through the nose.

A reasonable approach is to treat nasal NAD+ as an optional extra rather than a foundation. If you are already sleeping well, moving regularly and eating sensibly, adding an unproven delivery method is unlikely to be the thing that changes your trajectory. If you are not doing those things, no spray will compensate.

Frequently asked questions

Does NAD+ nasal spray actually raise NAD+ levels?

Nobody knows with confidence. There is no published human data establishing that nasal administration produces a measurable rise in systemic NAD+ levels. The mechanism is plausible in theory but unconfirmed in practice.

Is it safer than an infusion?

It is less invasive, which is a genuine advantage for comfort and convenience. Whether it is safer in a clinical sense is unanswerable without safety data. Infusions are administered under supervision, which provides a layer of oversight that a self-administered spray does not.

Should I ask my doctor first?

Yes. Any new product that claims to influence cellular metabolism should be discussed with a clinician who knows your medical history and current prescriptions. That is especially true if you are pregnant, breastfeeding, managing a chronic condition or taking regular medication.

The wider point is one about evidence hierarchies. NAD+ is a genuine and important molecule. The interest in it is scientifically legitimate. But legitimacy at the level of biochemistry does not transfer automatically to every product that borrows the name. Nasal delivery is an interesting idea with an unproven track record, and the most useful thing a reader can bring to it is a clear-eyed sense of the difference between a mechanism and a result.

This article is part of an ongoing editorial series. Information current as of publication date.